ストックスクリーナーアプリを入手
2.4409
2.20%
-0.0591
前日終値:
$2.50
開ける：
$2.48
24時間の取引高:
411.73K
Relative Volume:
0.61
時価総額：
$174.66M
収益：
-
当期純損益:
$-117.50M
株価収益率:
-0.9535
EPS:
-2.56
ネットキャッシュフロー:
$-114.31M
1週間 パフォーマンス:
-9.44%
1か月 パフォーマンス:
-42.06%
6か月 パフォーマンス:
-62.56%
1年 パフォーマンス:
-3.36%
1日の値動き範囲:
$2.395
$2.51
1週間の範囲:
$2.38
$2.735
52週間の値動き範囲:
$2.38
$16.24
Nkarta Inc Stock (NKTX) Company Profile
名前
Nkarta Inc
セクター
電話
(925) 407-1049
住所
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| NKTX | 2.4499 | 174.66M | 0 | -117.50M | -114.31M | -2.56 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.00 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.61 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.08 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-09 | 開始されました | Rodman & Renshaw | Buy |
| 2024-08-14 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-28 | 開始されました | Needham | Buy |
| 2022-07-18 | 開始されました | SVB Leerink | Outperform |
| 2022-03-11 | 開始されました | Raymond James | Outperform |
| 2022-03-08 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-06 | 開始されました | William Blair | Outperform |
| 2021-11-18 | 開始されました | SMBC Nikko | Outperform |
| 2021-07-16 | 開始されました | Oppenheimer | Outperform |
| 2020-08-04 | 開始されました | Cowen | Outperform |
| 2020-08-04 | 開始されました | Evercore ISI | Outperform |
| 2020-08-04 | 開始されました | Mizuho | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Nkarta Inc (NKTX) 最新ニュース
Nkarta price target lowered to $16 from $20 at Mizuho - TipRanks
NKTX stock touches 52-week low at $2.44 amid market fluctuations - Investing.com UK
Despite Hitting US$2.91, Nkarta Insiders Still Sold Too Soon - Simply Wall St
Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more - BioSpace
Nkarta to Participate in an Upcoming Investor Conference - The Manila Times
Nkarta to Present at Stifel Healthcare Conference: NK Cell Therapy Updates Expected | NKTX Stock News - StockTitan
Nkarta (NASDAQ:NKTX) Price Target Cut to $18.00 by Analysts at HC Wainwright - MarketBeat
Nkarta (NASDAQ:NKTX) Given New $11.00 Price Target at Needham & Company LLC - MarketBeat
Nkarta, Inc. Reports Q3 2024 Financial Results - TipRanks
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta, Inc. (NASDAQ:NKTX) Receives $17.50 Average PT from Brokerages - Defense World
Brokerages Set Nkarta, Inc. (NASDAQ:NKTX) Price Target at $17.50 - MarketBeat
Nkarta (NKTX) Stock: Looking For Upside - Seeking Alpha
Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade) - Seeking Alpha
SG Americas Securities LLC Purchases New Shares in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Bleakley Financial Group LLC Has $69,000 Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth - Yahoo Finance
GAMMA Investing LLC Increases Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Are Nkarta Inc (NKTX) shares a good deal now? - US Post News
Daily Market Movement: Nkarta Inc (NKTX) Sees a 1.29 Increase, Closing at 3.94 - The Dwinnex
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Dimensional Fund Advisors LP - Defense World
AQR Capital Management LLC Invests $938,000 in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta Inc (NKTX) Stock: A Year of Market Fluctuations - The InvestChronicle
Nkarta (NASDAQ:NKTX) Stock Rating Upgraded by RODMAN&RENSHAW - Defense World
Nkarta (NASDAQ:NKTX) Upgraded to "Strong-Buy" by RODMAN&RENSHAW - MarketBeat
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Nkarta (NASDAQ:NKTX) Coverage Initiated by Analysts at Rodman & Renshaw - MarketBeat
Raymond James upgrades Nkarta Inc (NKTX) stock to a Strong buy - Knox Daily
Nkarta upgraded at Raymond James on valuation - MSN
A History of Outperforming Analyst Forecasts and Beating the Odds: Nkarta Inc (NKTX) - SETE News
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - Benzinga
Metric Analysis: Nkarta Inc (NKTX)’s Key Ratios in the Limelight - The Dwinnex
Nkarta Inc (NKTX) stock on the rise: An overview - US Post News
American Century Companies Inc. Has $427,000 Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Anchoring Your Portfolio: Is NKTX Stock a Safe Harbor? - The InvestChronicle
Marshall Wace LLP Grows Stake in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Marshall Wace LLP - Defense World
It makes sense and dollars to buy Nkarta Inc (NKTX) stock - SETE News
Cubist Systematic Strategies LLC Invests $1.49 Million in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Nkarta Inc (NKTX) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Nkarta's SWOT analysis: NK cell therapy stock shows promise amid risks - Investing.com India
Forefront Analytics LLC Invests $70,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Renaissance Technologies LLC Acquires 98,000 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Inc [NASDAQ: NKTX] Sees Decrease in Stock Value - Knox Daily
Nkarta, Inc. (NASDAQ:NKTX) Shares Sold by Deerfield Management Company L.P. Series C - MarketBeat
Rhumbline Advisers Acquires 33,117 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Purchases New Shares in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Affinity Asset Advisors LLC Takes Position in Nkarta, Inc. (NASDAQ:NKTX) - MarketBeat
Wall Street analysts’ outlook for Nkarta Inc (NKTX) - SETE News
Nkarta Inc (NKTX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 5.21 - The Dwinnex
Nkarta Inc (NKTX) 財務データ
収益
当期純利益
現金流量
EPS
Nkarta Inc (NKTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Trager James | Chief Scientific Officer |
Jun 18 '24 |
Sale |
5.60 |
456 |
2,554 |
150,959 |
| HASTINGS PAUL J | Chief Executive Officer |
Jun 18 '24 |
Sale |
5.60 |
1,770 |
9,912 |
240,737 |
| Shook David | Chief Medical Officer |
Jun 18 '24 |
Sale |
5.60 |
456 |
2,554 |
116,524 |
| Hager Alicia J. | Chief Legal Officer |
Jun 18 '24 |
Sale |
5.60 |
727 |
4,071 |
107,215 |
| Brandenberger Ralph | Chief Technical Officer |
Jun 18 '24 |
Sale |
5.60 |
229 |
1,282 |
79,743 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 27 '24 |
Buy |
10.00 |
3,000,000 |
30,000,000 |
10,050,818 |
| George Simeon | Director |
Mar 27 '24 |
Buy |
10.00 |
2,000,000 |
20,000,000 |
1,548,341 |
| Brandenberger Ralph | Chief Technical Officer |
Mar 01 '24 |
Option Exercise |
3.89 |
6,763 |
26,308 |
88,339 |
| Brandenberger Ralph | Chief Technical Officer |
Mar 01 '24 |
Sale |
12.51 |
8,367 |
104,671 |
79,972 |
| Trager James | Chief Scientific Officer |
Feb 12 '24 |
Sale |
12.00 |
4,143 |
49,716 |
149,415 |
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):